PH

Petrichor Healthcare Capital Management

North America, New York, United States, New York

Description

Petrichor Healthcare Capital Management provide customized investment structures and support.

Investor Profile

Petrichor Healthcare Capital Management has made 20 investments, with 3 in the past 12 months and 65% as lead.

Stage Focus

  • Post Ipo Equity (30%)
  • Series Unknown (15%)
  • Debt Financing (10%)
  • Post Ipo Debt (10%)
  • Series C (10%)
  • Series D (5%)
  • Series B (5%)
  • Convertible Note (5%)
  • Series A (5%)
  • Seed (5%)

Country Focus

  • United States (80%)
  • Germany (15%)
  • United Kingdom (5%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Health Diagnostics
  • Biopharma
  • Pharmaceutical
  • Therapeutics
  • Life Science
  • Innovation Management
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Petrichor Healthcare Capital Management frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
BP
North America, California, United States, San Francisco
Co-Investments: 1
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 2
Flying L Partners
North America, Colorado, United States, Steamboat Springs
Co-Investments: 2
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 2
FV
North America, California, United States, Menlo Park
Co-Investments: 2
Deep Track Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 1
Gore Range Capital
North America, New York, United States, New York
Co-Investments: 2
CC
North America, New York, United States, New York
Co-Investments: 1
BioAdvance
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 2

What are some of recent deals done by Petrichor Healthcare Capital Management?

Geneoscopy

Saint Louis, Missouri, United States

Geneoscopy develops a screening methodology to noninvasively diagnose colorectal cancer using biomarkers in stool samples.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series CJan 8, 2025
Amount Raised: $105,000,000
Palvella Therapeutics

Wayne, Pennsylvania, United States

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

BiotechnologyHealth CareLife ScienceTherapeutics
Post Ipo EquityDec 13, 2024
Evergreen Theragnostics

Jersey City, New Jersey, United States

Evergreen Theragnostics is a contract development and manufacturing platform that provides radiopharmaceutical development services.

BiotechnologyManufacturing
Series CApr 16, 2024
Amount Raised: $26,000,000
Avalo Therapeutics

Rockville, Maryland, United States

Avalo Therapeutics is a clinical-stage biopharmaceutical company.

BiotechnologyTherapeutics
Post Ipo EquityMar 27, 2024
Amount Raised: $115,600,000
Fennec Pharmaceuticals

Durham, North Carolina, United States

Fennec Pharmaceuticals is a small stage biotechnology company developing sodium thiosulfate.

BiopharmaBiotechnologyHealth CarePharmaceutical
Post Ipo DebtDec 5, 2023
Amount Raised: $5,000,000
Ascend Gene & Cell Therapies

Potters Bar, Hertford, United Kingdom

Ascend Gene & Cell Therapies is a model for gene and cell therapy manufacturing.

BiotechnologyConsultingManufacturingTherapeutics
Series AMay 9, 2023
Amount Raised: $65,900,000
Vero Biotech

Atlanta, Georgia, United States

Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.

BiotechnologyHealth CareHealth DiagnosticsMedicalPharmaceutical
Series UnknownJan 11, 2023
Amount Raised: $30,000,000
Palvella Therapeutics

Wayne, Pennsylvania, United States

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

BiotechnologyHealth CareLife ScienceTherapeutics
Series DJan 5, 2023
Amount Raised: $37,700,000
Fennec Pharmaceuticals

Durham, North Carolina, United States

Fennec Pharmaceuticals is a small stage biotechnology company developing sodium thiosulfate.

BiopharmaBiotechnologyHealth CarePharmaceutical
Post Ipo EquityNov 11, 2022
Amount Raised: $25,000,000
Fennec Pharmaceuticals

Durham, North Carolina, United States

Fennec Pharmaceuticals is a small stage biotechnology company developing sodium thiosulfate.

BiopharmaBiotechnologyHealth CarePharmaceutical
Post Ipo DebtSep 26, 2022
Amount Raised: $20,000,000